Hers

United States Telehealth Weight Loss Market Report 2024-2028: Impacts of COVID and GLP-1 Meds Featuring Weight Watchers, Noom, Ro.co, , AmWell, Amazon, Teladoc, Form Health, Form Health Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, April 19, 2024
Fitness & Nutrition, Health, Telemedicine, Virtual Medicine, Internet, PEW, Pharmacy, Hers, McKinsey & Company, Noom, NIH, Map, Truist, Research, Weight loss, Growth, Obesity, PayScale, BLS, COVID-19, Physician, Indeed, Pew Research Center, Investment, Tutoring

This new Marketdata report presents an analysis of weight loss programs provided by various telehealth/telemedicine platforms.

Key Points: 
  • This new Marketdata report presents an analysis of weight loss programs provided by various telehealth/telemedicine platforms.
  • Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their physicians via Zoom video calls and by phone, email and chat.
  • Then, in 2021-2023, as demand for the GLP-1 weight loss medications took off, many of these telehealth providers added weight loss plans based on access to these drugs, plus support.
  • Includes profiles for: Weight Watchers Clinic, LifeMD/Medifast, Noom, Ro.co, Calibrate Health, AmWell, Amazon Health, Teladoc, Form Health (Lilly Direct), Hims & Hers, Mochi Health, Form Health, and 10 more.

Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024

Retrieved on: 
Monday, April 15, 2024
Other Health, Health, General Health, Women, Pharmaceutical, Men, Mental Health, Health Technology, Fitness & Nutrition, Consumer, Telemedicine, Virtual Medicine, Hers

Hims & Hers Health, Inc. ("Hims & Hers," NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2024 financial results after the market closes on Monday, May 6, 2024.

Key Points: 
  • Hims & Hers Health, Inc. ("Hims & Hers," NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2024 financial results after the market closes on Monday, May 6, 2024.
  • The company will host a live conference call to discuss the results at 5:00 p.m.
  • The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296.
  • A live audio webcast will be available at https://investors.hims.com and will be archived for one year.

Define Ventures Welcomes Frank Williams as Venture Partner

Retrieved on: 
Tuesday, April 9, 2024
ICER, Public health, UCSF, Health, Partnership, Advisory Council, Patient, SAN, Executive Committee, IPO, Brown University, Silicon, The Advisory Board Company, Hers, School

SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- Define Ventures, the largest firm focused on early-stage digital health companies, today announced veteran healthcare leader Frank Williams has joined its team as venture partner. Williams, who is the co-founder of Evolent Health and served as the company's CEO and chairman, will play a pivotal role in partnering with category-defining digital health companies and their exceptional entrepreneurs to grow and scale their businesses. This announcement follows the firm raising $460 million in 2023 across two new funds.

Key Points: 
  • SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- Define Ventures , the largest firm focused on early-stage digital health companies, today announced veteran healthcare leader Frank Williams has joined its team as venture partner.
  • "I've been really impressed with the Define team and who they've chosen to partner with.
  • "Frank has an unmatched track record in this industry, both as an incredible leader and extraordinary operator," said Lynne Chou O'Keefe, founder and managing partner at Define Ventures.
  • Define Ventures also has a deep bench of strategic advisors across healthcare, consumer, and tech to provide guidance in creating and scaling industry-leading companies.

Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member

Retrieved on: 
Thursday, April 4, 2024
Online Retail, Health, General Health, Women, Pharmaceutical, Men, Health Technology, Retail, Fitness & Nutrition, Consumer, Telemedicine, Virtual Medicine, Microsoft, EBay, Positronic brain, Mental health, History, Software, Life, Senior, Dermatology, Multimedia, Hers, DoorDash, Medicine, Management

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Christopher Payne to the company’s Board of Directors.

Key Points: 
  • Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Christopher Payne to the company’s Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20240403772620/en/
    Payne joins Hims & Hers board of directors to help the company further build on its leadership position within the personalized health and wellness space.
  • “He has a history of innovating across industries, building trusted brands globally, and evolving businesses to meet shifting customer needs.
  • Mr. Payne has also held leadership positions at Microsoft and Amazon, and currently serves on the board of directors of Gogo.

Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024

Retrieved on: 
Monday, March 11, 2024
Mental Health, Health, Telemedicine, Virtual Medicine, Fitness & Nutrition, General Health, Vitamins, Supplements, Hers, Virtual

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that members of the company’s management team will be participating in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024.

Key Points: 
  • Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that members of the company’s management team will be participating in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024.
  • All events will be webcast live and archived on the Hims & Hers investor relations website at https://investors.forhims.com .

PSEG Long Island Expands Partnership with Bidgely to Build Comprehensive Energy Efficiency Program

Retrieved on: 
Thursday, March 7, 2024
Other Energy, Utilities, Data Analytics, Energy, Artificial Intelligence, Data Management, Professional Services, Technology, EVS, Hers, EV, AMI, Multimedia, Success, Behavior, Electricity, Public Service Enterprise Group, Partnership

PSEG Long Island has expanded its partnership with Bidgely to execute an end-to-end energy efficiency solution that aligns with new time-of-day (TOD) regulatory priorities while continuing to promote significant energy savings and customer engagement.

Key Points: 
  • PSEG Long Island has expanded its partnership with Bidgely to execute an end-to-end energy efficiency solution that aligns with new time-of-day (TOD) regulatory priorities while continuing to promote significant energy savings and customer engagement.
  • Bidgely will also expand its customer engagement program with PSEG Long Island from roughly 550,000 customers to 700,000 customers.
  • View the full release here: https://www.businesswire.com/news/home/20240307139429/en/
    Expanded partnership between PSEG Long Island and Bidgely will empower consumers to save money, support grid stability, and make more efficient energy decisions.
  • Additionally, Bidgely’s true disaggregation capabilities will help PSEG Long Island identify and target customers with pool pumps and gas heating for energy efficiency and heat pump systems.

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Monday, February 26, 2024
Health, Consumer, Women, Other Health, General Health, Men, Pharmaceutical, Regulation S-K, Hers, Table, Regulation, GAAP, Adjustment, Video game

Gross margin was 83% for the fourth quarter of 2023 compared to 79% for the fourth quarter of 2022.

Key Points: 
  • Gross margin was 83% for the fourth quarter of 2023 compared to 79% for the fourth quarter of 2022.
  • Net income was $1.2 million for the fourth quarter of 2023 compared to a net loss of $(10.9) million for the fourth quarter of 2022.
  • Adjusted EBITDA was $20.6 million for the fourth quarter of 2023 compared to $3.9 million for the fourth quarter of 2022.
  • Free Cash Flow was $10.8 million for the fourth quarter of 2023 compared to $(9.3) million for the fourth quarter of 2022.

Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer

Retrieved on: 
Tuesday, February 20, 2024
General Health, Health, Telemedicine, Virtual Medicine, Other Health, Collection, Multimedia, SVP, Hers, Creative, DNA, Industrial design

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join the company’s executive team as the first Chief Design Officer.

Key Points: 
  • Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join the company’s executive team as the first Chief Design Officer.
  • Kenger currently serves as the SVP of Design at Hims & Hers and has been at the company since its founding.
  • View the full release here: https://www.businesswire.com/news/home/20240220023599/en/
    Hims & Hers Chief Design Officer Dan Kenger (Photo: Business Wire)
    “I started at Hims & Hers seven years ago with a commitment to deliver a truly thoughtful, accessible, personalized experience to every person who interacts with our brand,” said Kenger.
  • Pattern was born out of the agency Gin Lane, where Kenger was a partner and worked for more than 10 years.

Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

Retrieved on: 
Monday, February 5, 2024
Men, Other Retail, Online Retail, Pharmaceutical, Telemedicine, Virtual Medicine, Consumer, Mental Health, Health Technology, Cosmetics, Retail, Women, Vitamins, Supplements, Health, Hers, Conference

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Monday, February 26, 2024.

Key Points: 
  • Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Monday, February 26, 2024.
  • The company will host a live conference call to discuss the results at 5:00 p.m.
  • Hims & Hers also announced that members of the company’s management team will be participating in the Morgan Stanley Technology, Media & Telecom Conference on March 6, 2024 in San Francisco.
  • All events will be webcast live and archived on the Hims & Hers investor relations website at https://investors.forhims.com .

Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care

Retrieved on: 
Thursday, January 11, 2024
Health, Hospitals, Telemedicine, Virtual Medicine, Practice Management, Health Insurance, Managed Care, Carbon, Diabetes, Dermatology, Patient, ChristianaCare, Weight loss, Multimedia, Mount Sinai Health System, Partnership, Culture, Mental health, Carbon Health, Ochsner Health System, Hers, Hair loss, HHC, Transformation, Hospital

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, and Connecticut’s most transformative health system, Hartford HealthCare (HHC), today announced a strategic partnership that broadens access to in-person healthcare services.

Key Points: 
  • Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, and Connecticut’s most transformative health system, Hartford HealthCare (HHC), today announced a strategic partnership that broadens access to in-person healthcare services.
  • View the full release here: https://www.businesswire.com/news/home/20240111662974/en/
    The collaboration provides patients with an enhanced and connected healthcare experience when they need care outside the Hims & Hers platform.
  • This initiative reinforces Hims & Hers' mission to expand access to high-quality, affordable and convenient care by integrating an esteemed Connecticut-based healthcare system into its growing network of provider relationships.
  • HHC is known for many of its specialist care services, including for treatment of cardiovascular health, diabetes and prostate care.